GCP
AQST icon

GSA Capital Partners’s Aquestive Therapeutics AQST Stock Holding History

GSA Capital Partners’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-241,359
Closed -$1.35M – 1657
2025
Q3 		$1.35M Buy
241,359
+54,667
+29% +$236K 0.11% 230
2025
Q2 		$618K Buy
+186,692
New +$536K 0.04% 769
2024
Q4 		– Sell
-137,151
Closed -$683K – 1585
2024
Q3 		$683K Buy
137,151
+115,223
+525% +$448K 0.05% 708
2024
Q2 		$57K Buy
+21,928
New +$73.2K ﹤0.01% 1561
2023
Q4 		– Sell
-100,854
Closed -$154K – 1481
2023
Q3 		$154K Buy
100,854
+86,902
+623% +$149K 0.01% 1333
2023
Q2 		$23K Buy
+13,952
New +$25.2K ﹤0.01% 1441
2022
Q4 		– Sell
-13,704
Closed -$16K – 1443
2022
Q3 		$16K Buy
+13,704
New +$15.5K ﹤0.01% 1452
2022
Q2 		– Sell
-34,769
Closed -$91K – 1380
2022
Q1 		$91K Sell
34,769
-63,033
-64% -$184K 0.01% 1304
2021
Q4 		$380K Sell
97,802
-199,427
-67% -$1M 0.05% 775
2021
Q3 		$1.3M Buy
297,229
+199,428
+204% +$782K 0.13% 181
2021
Q2 		$388K Sell
97,801
-109,808
-53% -$439K 0.04% 790
2021
Q1 		$1.08M Buy
+207,609
New +$1.1M 0.18% 120
2019
Q2 		– Sell
-11,400
Closed -$79K – 1423
2019
Q1 		$79K Buy
+11,400
New +$79.9K 0.01% 1346

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GSA Capital Partners's AQST Position: Q4 2025 in Review

GSA Capital Partners sold out of Aquestive Therapeutics (AQST) in Q4 2025, closing a stake of 241,359 shares — an estimated $1.35M sold.

GSA Capital Partners first reported a position in AQST in Q1 2019 and held it in 13 quarters. The position peaked at $1.35M in Q3 2025. 176 funds tracked by Wall St. Rank hold AQST as of Q4 2025.

  • GSA Capital Partners reported no remaining Aquestive Therapeutics position as of Q4 2025 after selling out during the quarter.
  • GSA Capital Partners sold 241,359 Aquestive Therapeutics shares in Q4 2025, an estimated $1.35M.
  • GSA Capital Partners first reported a position in Aquestive Therapeutics in Q1 2019 and held it in 13 quarters.
  • GSA Capital Partners's Aquestive Therapeutics position peaked at $1.35M in Q3 2025.
  • 176 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2025.

Based on GSA Capital Partners's 13F filing for Q4 2025, filed 6 Feb 2026.